Condition: Peyronies Disease · Sponsor: Herlev Hospital
The purpose of this clinical trial is to evaluate the effects of Platelet-Rich Plasma (PRP) intralesional injections in men affected by Peyronie's disease (PD) in the fibrotic phase.
This description comes directly from the study's public registry record.
Mikael Heering, MD, Ph.d. student · +4538688964 · mikael.heering@regionh.dk
Mikkel M. Fode, Professor, MD, Ph.d. · +4538682093 · mikkel.mejlgaard.fode@regionh.dk
Always discuss trial participation with your own doctor first.
| Herlev and Gentofte University Hospital | Herlev, Denmark | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07117955